top of page
Medical Checkup

ARNASA

Trial Enrolment Status

CLOSED

Disease Under Study

COPD

Duration

~52 Weeks

About the Trial

Utilization of Astegolimab in Patients with Chronic Obstructive Pulmonary Disease With a History of Exacerbations

Mechanism of Action:

Anti IL-33/ST2

Dr. George Philteos

Principal Investigator

Dr. George Philteos

Sub-Investigator

Dr. Anushya Chelvanathan

Study Coordinator

Cynthia Lee

bottom of page